glutathione kills triple negative cancer Ferroptosis heterogeneity in triple-negative breast reveals an innovative immunotherapy combination strategy GSTP1 Is a Driver of
GSTP1 Is a Driver of Triple Negative Breast Cancer Cell Metabolism and Pathogenicity ScienceDirect Emerging mechanisms of triple negative breast cancer radioresistance: Interplay between cancer cell mechanisms and the tumor immune microenvironment Cancer Treatment Reviews Targeting the redox programmed cell death axis in breast cancer: from molecular mechanisms to therapeutic resistance Cell Death Discovery Excessive glutathione intake contributes to chemotherapy resistance in breast cancer: a propensity score matching analysis PMC Human cancer associated fibroblasts enhance glutathione levels and antagonize drug induced prostate cancer cell death Cell Death & Disease
Pay in 4 interest-free payments of $6.51 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4




